MiRNAs of peripheral blood as the biomarker of schizophrenia
Abstract The diagnosis of schizophrenia is currently based on the symptoms and bodily signs rather than on the pathological and physiological markers of the patient. In the search for new molecular targeted therapy medicines, and recurrence of early-warning indicators have become the major focus of...
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
BMC
2017-08-01
|
| Colección: | Hereditas |
| Materias: | |
| Acceso en línea: | http://link.springer.com/article/10.1186/s41065-017-0044-2 |